A nurse admits a child with a diagnosis of acute lymphoblastic leukemia (ALL). During each phase of treatment, which would most likely be seen periodically?

Choice A reason: Bone marrow transplant is reserved for high-risk or relapsed ALL, not routine across treatment phases. Complete remission is the goal periodically assessed, making this incorrect, as it’s not a standard periodic occurrence in the child’s treatment for acute lymphoblastic leukemia. Choice B reason: Relapse is a complication, not an expected periodic outcome in ALL treatment phases. Complete remission is regularly evaluated, making this incorrect, as it represents a failure rather than the anticipated progress in the child’s ongoing leukemia treatment protocol. Choice C reason: Complete remission, marked by no detectable leukemia cells, is the goal periodically assessed during ALL treatment phases. This aligns with pediatric oncology protocols, making it the correct outcome most likely seen as the child progresses through treatment for acute lymphoblastic leukemia. Choice D reason: Methotrexate injections into cerebrospinal fluid are specific to central nervous system prophylaxis, not periodic across all phases. Complete remission is routinely monitored, making this incorrect, as it’s not a universal periodic event in the child’s ALL treatment process.